Teligent's 3 Ch. 11 Asset Sales Bring $87M Into Estate
Bankrupt generic pharmaceutical company Teligent Inc. received court approval Tuesday in Delaware for three asset sales that generated more than $87 million in value for the debtor....To view the full article, register now.
Already a subscriber? Click here to view full article